Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

GPP

  • FDA Approval
  • June 14, 2024, 08:41 UTC
  • 26
  • 0 comments

FDA approve VALGANCICLOVIR HYDROCHLORIDE

Comment Full text

TORRENT PHARMS

  • FDA Approval
  • June 14, 2024, 08:41 UTC
  • 29
  • 0 comments

FDA approve RISPERIDONE

Comment Full text

NOVITIUM PHARMA

  • FDA Approval
  • June 14, 2024, 08:41 UTC
  • 21
  • 0 comments

FDA approve LEVORPHANOL TARTRATE

Comment Full text

NOVITIUM PHARMA

  • FDA Approval
  • June 14, 2024, 08:41 UTC
  • 23
  • 0 comments

FDA approve NAPROXEN

Comment Full text

BIOCRYST

  • FDA Approval
  • June 14, 2024, 08:41 UTC
  • 26
  • 0 comments

FDA approve PERAMIVIR

Comment Full text

TORRENT

  • FDA Approval
  • June 14, 2024, 08:41 UTC
  • 23
  • 0 comments

FDA approve ESOMEPRAZOLE MAGNESIUM

Comment Full text

CHARTWELL RX

  • FDA Approval
  • June 14, 2024, 08:41 UTC
  • 24
  • 0 comments

FDA approve RISPERIDONE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • June 14, 2024, 08:41 UTC
  • 21
  • 0 comments

FDA approve RIFAMPIN

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • June 14, 2024, 08:41 UTC
  • 21
  • 0 comments

FDA approve POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS

Comment Full text

MYLAN

  • FDA Approval
  • June 14, 2024, 08:41 UTC
  • 21
  • 0 comments

FDA approve EPOPROSTENOL SODIUM

Comment Full text
  • Previous
  • 329
  • 330
  • 331
  • 332
  • 333
  • Next

Search

News categories

  • Technical Exchange News(10033)
  • Event(412)
  • SEC News(169702)
  • FDA Approval(9405)
  • Company Report(721)
  • Business News(112980)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin